Independent life-science & consumer-health advisory · Europe and China
Someone of ours
will be in the room.
We take European pharma, medtech, diagnostics and consumer-health companies into China, and Chinese manufacturers into Europe. We run the interviews ourselves, in Mandarin. We negotiate with the distributor ourselves. And where the work needs someone to stay and run it, a partner stays.
Where you are
We are considering China
You need to know whether it is feasible, in what order, and with whom — before you commit capital or a team.
Entering China → Already thereWe are in China and it is not working
The distributor covers three provinces out of thirty-one, or the registration stalled, or the price fell in a procurement round nobody in Europe saw coming.
An independent read → Going out · 出海We are Chinese and Europe is next
Twenty-seven health systems, a notified-body queue, and the question of who ends up holding your registration.
Entering Europe →Where we go deep
Rare Disease
Orphan pathways, catalogue access, patient associations, and the pricing conversation that follows approval.
Dental
Clinics, dental service organisations, volume-based procurement, and keeping control of brand and price.
Consumer Health
Dermocosmetics, cosmetics and food supplements — where the claim you make decides the channel you can sell in.
Health & Sport
Where sport, physical activity and health policy meet — what a company may claim, which channel that opens, and who to build it with, in Europe and China.
Across all four: pharmaceuticals, biotech, medical devices, diagnostics and laboratory tools.
Your path into the other market
Three moves, and you can buy the first one on its own
Most failures on this corridor are sequencing failures, not strategy failures. You do not have to commit to all three — most relationships with us start with a single scoped piece of the first.
See the market yourself, before you commit
Field research, not desk summaries. We interview the people who actually buy, prescribe, distribute and reimburse.
- Market study and primary interviews
- Voice-of-customer and KOL research
- Competitive and pricing landscape
- Discovery programmes, both directions
Enter in the right order
Regulatory pathway, distributor qualification, pricing, and a team on the ground — without you building an organisation first.
- Regulatory strategy (NMPA · CE / MDR-IVDR)
- Distributor identification and qualification
- Cross-border e-commerce and general trade
- Part-time management and expertise
Hold the market once it opens
The stage most advisers skip, and where most of our work with long-standing clients happens. Building the local team, the processes and the governance that decide whether year three looks like year one.
- Operating model and organisation design
- Joint-venture governance
- Capability building and recruitment
- Local entity setup and operations
What makes us different
We do not stop at the recommendation.
Unlike advisers focused on high-level analysis, we take responsibility for informed execution — anchored in verified regulatory, commercial and field-level realities.
Services
Eight things you can engage us for
Every one of them runs in both directions of the corridor. Each has a page saying who it is for, who it is not for, what you receive, what it costs, how long it takes and who leads it.
Market study & primary interviews
Interviews with the people who actually buy, prescribe, distribute and reimburse — run by us, in their language, and yours alone afterwards.
What it involves → Scoped engagementRegulatory pathway & market access
Which regime applies to your product, what the calendar really is, and what approval does and does not buy you.
What it involves → Scoped engagementDistributor search & qualification
Route to market, a qualified shortlist no candidate has paid to be on, and terms that keep brand, price and registration yours.
What it involves → Ongoing mandateChina market activation & guardianship
The mandate that starts the day the contract is signed: distributor governance, price discipline, and someone of ours accountable for the market.
What it involves → Ongoing mandateBranding & marketing
Brand, claims and go-to-market for a market that reads your category differently — with agency execution coordinated, not improvised.
What it involves → Ongoing mandateOn the ground with you
Part-time operational management, or senior expertise by the day. A named partner accountable for an outcome, not a document.
What it involves → Ongoing mandateOrganisation & operating model
Team, governance and operating model — the part of an entry that has no regulatory deadline and quietly decides year three.
What it involves → Ongoing mandateEcosystem discovery programme
A designed programme of encounters that lets a leadership team meet a market properly before committing to it.
What it involves →Sector practices
Where we go deep — in both directions
How it fits togetherRare Disease
Regulatory sequencing, RDL inclusion, genetic-testing access and NRDL pricing scenarios.
PracticeDental
Distribution control, city-tier reality and pilot launches in a USD 22 bn market.
PracticeConsumer Health
Medical cosmetics, dermocosmetics and supplements — registration, channel and claims.
PracticeHealth & Sport
Where sport, physical activity and health policy meet — what a company may claim, which channel that opens, and who to build it with, in Europe and China.
ProgrammeDiscovery Programmes
A designed visit, not a conference: three to five days of arranged meetings with the European or the Chinese health ecosystem, for a leadership team deciding whether to commit.
PublishingInsights
Notes every two weeks, analysis when something moves, two white papers a year.
Insights
Notes from the corridor
All insights“Set up a Chinese company, not a Chinese branch”
Yong Yan on the single mindset shift she asks every arriving executive to make.
White paper · Jan 2026Strategic Entry into China's Rare Disease Market
Regulatory sequencing, diagnostic readiness and NRDL pricing scenarios.
Note · Oct 2025Three funding logics, twenty-seven markets
Why the first European country you choose decides who buys and how price is set.
Before you decide
What it costs to get this wrong
An exclusive signed in month three
Distribution agreements are easy to sign and slow to leave. Two years to unwind is normal, and during those two years the market forms its opinion of your brand without you.
A registration you do not hold
If the partner owns the certificate, the partner owns the market. Recovering it means starting the regulatory calendar again, with a competitor now in the room.
A calendar built on the published timetable
Approval arriving eleven months after the plan said it would is not a delay. It is a budget cycle, a launch window and, often, a sponsor.
One attempt
A European mid-cap gets one serious run at China before the board stops funding it. The second attempt is always harder to authorise than the first.
How we work
You always know who pays us
Some engagements are fee-only; business development can carry success-linked compensation. Whichever applies, the structure is agreed with you in writing before the work starts and it is in the Scope of Work.
Priced before you commit
A detailed, line-by-line quote — named people, day rates, day counts — so you can remove anything you do not want and benchmark what is left.
A partner replies, not a salesperson
The partner who scopes the work is the partner who does it. Expect an answer within two working days.
All three appear in every Scope of Work. If we are not the right firm for the question, we say so — and, where we can, say who is.
In their words
“Jumo has demonstrated high capacity to understand international management standards and how to deploy them in the context of a Chinese JV — at all levels of the organisation, Board and senior management included.”
“ELITechGroup is able to develop its Molecular Diagnostics business in China thanks to the professionalism and dedication of Jumo.”
The next step
Start with a conversation, not a proposal.
Thirty minutes with a partner. Tell us the market, the product, and what you are trying to work out — and you leave with a view, whether or not you go further with us. If your procurement team needs to see us first, ask for the pack instead.